Redesigning the Care Journey of Patients With Single-ventricle Congenital Heart Disease
NCT ID: NCT04613934
Last Updated: 2021-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
142 participants
OBSERVATIONAL
2020-02-04
2020-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device Under a Continued Access Protocol
NCT01242891
Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle
NCT04842851
Reprieve System Pilot Study
NCT06272734
Adaptive Servo-Ventilation In Acute Heart Failure Patients Protecting the Heart and Kidneys
NCT02796638
PCORI-1310-06998 Trial of a Decision Support Intervention for Patients and Caregivers Offered Destination Therapy Heart Assist Device
NCT02344576
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will take part in an Experience Group. The Experience Group methodology is a form of qualitative research that brings together a group of 4-8 people who share similar medical circumstances for a conversation. This methodology has been successfully used by researchers from the Value Institute for Health and Care to gain insights in different patient populations. The groups will take place at Dell Medical School, The Dell Pediatric Research Institute (across the street from Dell Children's Medical Center), or other convenient public location as needed to allow for the least amount of travel for participants. Each group lasts 60-90 minutes and encourages participants to discuss their conditions and experiences outside the hospital/clinic, specifically. Focusing on the lifestyle aspect of the patient experience enables insight into both the successes and the challenges faced outside the health care system and in unobservable situations. Conversation is encouraged by the facilitator, who offers topics such as "what makes a good/bad day?", "what are your aspirations, what are your fears?", and "what are some of the obstacles and burdens you face on a regular basis?" Using a research approach that employs semi-structured, open-ended questions directed towards the group as a whole, the investigators hope to learn about the unarticulated, unmet needs of these patients, both physical and emotional, and ranging both within and outside of the clinic. Participants will not be asked to take part in more than one Experience Group session. Due to the current COVID-19 pandemic, Experience Group sessions will be held virtually via Zoom.
Participants can elect to participate in a follow-up Contextual Interview following the Experience Groups. If the participants provide consent, they may be contacted for an interview. Not every patient that consents for participation will be asked to participate. Contextual Interviews will take place in participant's homes, or any other place of their choosing where they feel comfortable. Contextual Interviews will be performed by up to three personnel from the Design Institute for Health. The Design Institute has used this methodology extensively to identify needs and insights from patients to redesign care. Upon completion and approval of the optional model release part of the informed consent, audio recordings and photos may be taken. The Contextual Interviews do not follow a rigid question / answer scheme. Instead, their tone is conversational. Interview prompts will center around challenges the patients and families faced in their journey with CHD. Example questions may include, "When did you first receive the diagnosis?", "How do you feel about the care you were receiving?", "What, if anything, did the care team do to make you feel cared for?", "How did you feel about the location/environment?", and "What, if anything could have been different, improved or better for you?" Participants will not be asked to take part in more than one Contextual Interview session. Due to the current COVID-19 pandemic, Contextual Interviews will take place virtually via Zoom.
Finally, some participants will have the opportunity to take part in virtual workshops to discuss the challenges uncovered in the Experience Groups and Contextual Interviews and ideate potential solutions to such challenges. Workshops are ideation meetings lasting from a few hours to a full day and would include stakeholders from all three collaborators and patient and family representatives, if appropriate. Participants in workshops will be asked to comment on research insights, participate in ideation sessions (brainstorms), sketch and write up ideas and evaluate different service design concepts.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parents or legal guardians of patients at any age with any diagnosis of single-ventricle congenital heart disease
* Siblings of patients with any diagnosis of single-ventricle congenital heart disease, age 6 and older
* Pregnant parents who have gotten any prenatal diagnosis of single-ventricle congenital heart disease
* Adult partners of adult patients with any diagnosis of single-ventricle congenital heart disease
Exclusion Criteria
* Patients, family members, and partners who do not speak English or Spanish
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas at Austin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlos Miguel Mery
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos M Mery, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Texas at Austin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas at Austin
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mery CM, Well A, Taylor K, Carberry K, Colucci J, Ulack C, Zeiner A, Mizrahi M, Stewart E, Dillingham C, Cook T, Hartounian A, McCullum E, Affolter JT, Van Diest H, Lamari-Fisher A, Chang S, Wallace S, Teisberg E, Fraser CD Jr. Examining the Real-Life Journey of Individuals and Families Affected by Single-Ventricle Congenital Heart Disease. J Am Heart Assoc. 2023 Mar 7;12(5):e027556. doi: 10.1161/JAHA.122.027556. Epub 2023 Feb 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-08-0031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.